secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2023-09-15T23:59:59+00:00
Accession:  0001213900-23-077043
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Pharma gets Nasdaq bid-price deficiency notice; 180-day cure period
--------------------------------------------------------------------------

- Nasdaq notified Citius on Sept 12, 2023 that bid price closed below $1.00 for 30 consecutive business days.
- Company has until March 11, 2024 to regain compliance; must close at $1.00+ for 10 consecutive days.
- If not compliant by March 2024, may be eligible for an additional 180-day period, subject to other listing standards.
- Company is evaluating options; no immediate effect on listing under symbol CTXR.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390023077043/0001213900-23-077043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390023077043/ea185196-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-077043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer